Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • AChR
    (1)
  • BTK
    (1)
  • Calcium Channel
    (1)
  • EGFR
    (1)
  • JAK
    (1)
  • Others
    (4)
TargetMol | Tags By ResearchField
  • Cardiovascular disease
    (1)
  • Tumor/Cancer
    (6)
Filter
Search Result
Results for "

vascularization

" in TargetMol Product Catalog
  • Compound Libraries
    7
    TargetMol | Activity
  • Inhibitor Products
    6
    TargetMol | inventory
  • Recombinant Protein
    5
    TargetMol | natural
Anti-Cancer Compound Library
L2100
A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
  • $94,750
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Anti-Cancer Active Compound Library
L2160
A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
  • $56,480
Backorder
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Anti-Cancer Clinical Compound Library
L2120
A unique collection of 2545 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);
  • $45,870
Backorder
Size
QTY
TargetMol | Citations Cited
Angiogenesis related Compound Library
L4800
A unique collection of 1353 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);
  • $36,910
Backorder
Size
QTY
TargetMol | Citations Cited
Anti-Cancer Drug Library
L2150
A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);
  • $55,460
Backorder
Size
QTY
TargetMol | Citations Cited
Anti-Cancer Approved Drug Library
L2110
A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);
  • $31,940
Backorder
Size
QTY
TargetMol | Citations Cited
Anti-Cancer Compound Library Plus
L2180
Well-chosen 1468 anti-tumor compounds with unique structures;
  • $36,250
Backorder
Size
QTY
TargetMol | Citations Cited